Altuzan (Avastin) 400 MG 16 ML


AVASTIN®, in combination with intravenous 5‑fluorouracil‑based chemotherapy, is indicated for first- or second‑line treatment of patients with metastatic carcinoma of the colon or rectum. Avastin, in combination with carboplatin and paclitaxel, is indicated for first‑line treatment of patients with unresectable, locally advanced, recurrent or metastatic non-squamous, non-small cell lung cancer.


There are no reviews yet.

Be the first to review “Altuzan (Avastin) 400 MG 16 ML”

Your email address will not be published. Required fields are marked *